drugset / Trial / NCT05772104
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.
Timeline
- Start
- 2023-04-17
- Primary completion
- 2025-02-28
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shugan Jieyu Capsules | Unknown | 4 unknown | Oral |